Gebro Pharma GmbH
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1947-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.gebro.com
Clinical Trials
5
Active:3
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 4
1 (50.0%)Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee
Phase 4
Completed
- Conditions
- Osteoarthritis of the Hip or Knee
- Interventions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Gebro Pharma GmbH
- Target Recruit Count
- 482
- Registration Number
- NCT01066676
- Locations
- 🇦🇹
Rehabzentrum für Erkrankungen des rheumat. Formenkreises, Bad Hofgastein, Salzburg, Austria
🇦🇹Rheuma Zentrum Favoriten, Vienna, Austria
S(+)-Ibuprofen Effects on Asprin Treated Volunteers
Phase 1
Completed
- Conditions
- Drug Interactions
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2012-03-13
- Lead Sponsor
- Gebro Pharma GmbH
- Target Recruit Count
- 72
- Registration Number
- NCT00442585
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria
News
No news found